The Effect of Irisin on Proliferation, Apoptosis, and Expression of Metastasis Markers in Prostate Cancer Cell Lines.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 377, doi. 10.1007/s40487-022-00194-4
- By:
- Publication type:
- Article
Works in Oncology & Therapy, 2022, Vol 10, Issue 2
Results: 15
1
2
The Role of Electronic Patient-Reported Outcome Measures in Assessing Smoking Status and Cessation for Patients with Lung Cancer.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 481, doi. 10.1007/s40487-022-00210-7
- By:
- Publication type:
- Article
3
The Anticancer Effect of Metformin Combined with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients with or Without Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 363, doi. 10.1007/s40487-022-00209-0
- By:
- Publication type:
- Article
4
Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational Study.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 463, doi. 10.1007/s40487-022-00208-1
- By:
- Publication type:
- Article
5
Pegfilgrastim Biosimilars in US Supportive Oncology: A Narrative Review of Administration Options and Economic Considerations to Maximize Patient Benefit.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 351, doi. 10.1007/s40487-022-00207-2
- By:
- Publication type:
- Article
6
The Implementation of Minimally Invasive Surgery in the Treatment of Esophageal Cancer: A Step Toward Better Outcomes?
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 337, doi. 10.1007/s40487-022-00206-3
- By:
- Publication type:
- Article
7
Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 451, doi. 10.1007/s40487-022-00205-4
- By:
- Publication type:
- Article
8
MRI Grading Scale Predicts Ambulatory Function After Radiotherapy for Metastatic Spinal Cord Compression: A Prospective Single-Institution Observational Study.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 493, doi. 10.1007/s40487-022-00204-5
- By:
- Publication type:
- Article
9
Minimally Invasive Pancreatoduodenectomy: Contemporary Practice, Evidence, and Knowledge Gaps.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 301, doi. 10.1007/s40487-022-00203-6
- By:
- Publication type:
- Article
10
Breast Cancer with Low Recurrence Score on Oncotype DX<sup>©</sup>: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 441, doi. 10.1007/s40487-022-00202-7
- By:
- Publication type:
- Article
11
Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 317, doi. 10.1007/s40487-022-00201-8
- By:
- Publication type:
- Article
12
Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-Making.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 421, doi. 10.1007/s40487-022-00200-9
- By:
- Publication type:
- Article
13
Correction to: The Effect of Irisin on Proliferation, Apoptosis, and Expression of Metastasis Markers in Prostate Cancer Cell Lines.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
14
Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 411, doi. 10.1007/s40487-022-00198-0
- By:
- Publication type:
- Article
15
Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT).
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 391, doi. 10.1007/s40487-022-00197-1
- By:
- Publication type:
- Article